癌痛规范化病房中癌痛治疗药物的应用分析  

Application analysis of analgesics for cancer pain in the pain standardization wards

作　　者：杨彩艳[1] 柳全霞[2] 张妍[3] 许大庆[1] 

机构地区：[1]银川市第一人民医院药学部,宁夏银川750001 [2]宁夏医科大学总院肿瘤医院,宁夏银川750004 [3]宁夏医科大学药学院,宁夏银川750004

出　　处：《中国药物应用与监测》2016年第4期235-237,242,共4页Chinese Journal of Drug Application and Monitoring

基　　金：宁夏回族自治区科技支撑计划项目(2015BY097)

摘　　要：目的:了解某三甲医院癌痛治疗药物的使用情况,为临床合理使用癌痛治疗药物提供参考。方法:采用回顾性调查法,对某三甲医院肿瘤内科住院患者2013–2015年期间使用的癌痛治疗药物数据进行统计,计算各药物总用量、总金额和DDDs,并对癌痛治疗药物的使用进行合理性评价。结果:吗啡缓释片连续3年DDDs和金额排序均位于第一位,且消耗量呈逐年增加趋势。哌替啶注射液的消耗量呈逐年下降趋势。无创给药途径选择率呈逐年上升趋势。结论:该院癌痛规范化病房中癌痛治疗药物的使用符合WHO癌痛三阶梯治疗原则,但在细节管理方面仍需进一步规范。Objective： To investigate and analyze the application of analgesics for patients with cancer pain in a grade 3 and first-class hospital, in order to provide references and suggestions for rational use of analgesics in clinical practice. Methods： With retrospective method, the data of analgesics used for inpatients with cancer pain in medical oncology from 2013 to 2015 were calculated statistically in respect of the total amount, the total consumption sum and DDDs, and then the rationality of use of analgesics was evaluated. Results： DDDs and the sales amount of morphine sustained release tablets ranked the first place during 3 years, and the consumption was growing every year. The consumption of pethidine injection declined year by year. The non-invasive delivery methods were selected more and more. Conclusion： The use of the analgesics for cancer pain in the pain standardization wards was in line with the three step analgesic ladder recommended by WHO, while further details management in terms of rational drug use should be strengthened.

关 键 词：癌痛治疗药物 用药分析 DDDS 

分 类 号：R95[医药卫生—药学]